DPP4 and plasma cell myeloma: IHC analysis also revealed that myeloma cells that remained untreated with HDACi expressed low or slightly detectable level of CD26, whereas myeloma cells treated with each HDACi for 48 hours showed moderately or intensely stained CD26 expression (Fig. 1D).